Both in Pharmaceuticals
Arrowhead Research vs Madrigal Pharmaceuticals
Over the past year ARWR returned +50.3% and MDGL returned −3.9%; their daily moves had a correlation of 0.24.
ARWR +50.3% MDGL −3.9%Growth of $1, one year, split-adjusted
| Metric | ARWR | MDGL |
|---|---|---|
| Price | $59.53 | $396.32 |
| Market cap | $8.41B | $9.16B |
| Today | −0.07% | −8.08% |
| 1 month | −4.5% | −19.7% |
| 6 months | −20.6% | −21.1% |
| Year to date | −10.3% | −31.9% |
| 1 year | +40.4% | −5.4% |
| Revenue growth (YoY) | +171.0% | +71.2% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −258.2% | −15.9% |
| P/E (TTM) | — | — |
| Price / sales | 12.6× | 7.1× |
| Net cash | $737.9M | $498.0M |
| Dividend yield | — | — |
| Volatility (60d) | 45.1% | 35.1% |
| Short % of float | 8.1% | 14.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).